ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
87,636.67
0.47%
S&P 500
5,752.40
-0.45%
Dow Jones
42,451.23
-0.16%
US Dollar vs Yen
149.016
-0.52%
Brent Oil
68.54
-3.51%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ

  6. UroGen Pharma Ltd (URGN) 銘柄情報

UroGen Pharma Ltd

UroGen Pharma Ltd (URGN)

NASDAQ
10.04
0.44
( 4.58% )
更新日時： 00:58:07
15分遅延
高度なチャート

個人投資家向けのプロ仕様のツール。

プレミアム

主要統計と詳細

通貨
10.04
買値
10.04
売値
10.09
出来高
51,596
9.65 日の範囲 10.06
9.03 52 週間の範囲 20.70
時価総額
423.682M
前日終値
9.60
始値
9.71
時刻
200
@
10.04
最終取引時間
00:57:31
財務取引量
US$ 509,502
VWAP
9.8748
平均取引量 (3 か月)
388,997
発行済株式数
42,199,414
配当利回り
-
PER
-4.06
1 株当たり利益 (EPS)
-2.42
歳入
82.71M
純利益
-102.24M

UroGen Pharma Ltd について

UroGen Pharma Ltd is a clinical stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies. The company has an innovative and broad pipeline of product candidates that can overcome the deficiencies of current treatment opt... UroGen Pharma Ltd is a clinical stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies. The company has an innovative and broad pipeline of product candidates that can overcome the deficiencies of current treatment options for a variety of urological conditions with a focus on uro-oncology. Its lead product candidates, UGN-101 and UGN-102, are proprietary formulations of the chemotherapy drug Mitomycin C, or MMC, a generic drug, which is used off-label for urothelial cancer treatment only in a water-based formulation as an adjuvant, or supplemental post-surgery, therapy. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
www.urogen.com
本社
Ra'anana, Center, Isr
設立
-
UroGen Pharma Ltd is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker URGN. The last closing price for UroGen Pharma was US$9.60. Over the last year, UroGen Pharma shares have traded in a share price range of US$ 9.03 to US$ 20.70.

UroGen Pharma currently has 42,199,414 shares in issue. The market capitalisation of UroGen Pharma is US$405.11 million. UroGen Pharma has a price to earnings ratio (PE ratio) of -4.06.

URGN 最新ニュース

その他のニュース

Form 8-K - Current report
Edgar (US Regulatory)
2025年2月20日
URGN (4.58%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
2025年2月5日
URGN (4.58%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
2025年2月5日
URGN (4.58%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
2025年2月5日
URGN (4.58%)
期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.535.57308096749.5110.149.034165369.43274499CS
4-1.25-11.07174490711.2911.879.0338032110.15171095CS
12-2-16.611295681112.0412.049.0338899710.55164963CS
26-3.39-25.241995532413.4314.579.0348196311.80968414CS
52-8.33-45.345672291818.3720.79.0349945013.82753023CS
1563.9665.13157894746.0824.134.8531812113.91422566CS
260-19.22-65.686944634329.2630.894.8525527515.25562505CS

URGN - Frequently Asked Questions (FAQ)

What is the current UroGen Pharma share price?
The current share price of UroGen Pharma is US$ 10.04
How many UroGen Pharma shares are in issue?
UroGen Pharma has 42,199,414 shares in issue
What is the market cap of UroGen Pharma?
The market capitalisation of UroGen Pharma is USD 405.11M
What is the 1 year trading range for UroGen Pharma share price?
UroGen Pharma has traded in the range of US$ 9.03 to US$ 20.70 during the past year
What is the PE ratio of UroGen Pharma?
The price to earnings ratio of UroGen Pharma is -4.06
What is the cash to sales ratio of UroGen Pharma?
The cash to sales ratio of UroGen Pharma is 5.02
What is the reporting currency for UroGen Pharma?
UroGen Pharma reports financial results in USD
What is the latest annual turnover for UroGen Pharma?
The latest annual turnover of UroGen Pharma is USD 82.71M
What is the latest annual profit for UroGen Pharma?
The latest annual profit of UroGen Pharma is USD -102.24M
What is the registered address of UroGen Pharma?
The registered address for UroGen Pharma is 9 HATAASIYA ST, PO BOX 2397, RA'ANANA, CENTER, 4365007
What is the UroGen Pharma website address?
The website address for UroGen Pharma is www.urogen.com
Which industry sector does UroGen Pharma operate in?
UroGen Pharma operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
GVVisionary Holdings Inc
US$ 2.255
(74.81%)
101.41M
CMRXChimerix Inc
US$ 8.4275
(69.91%)
99.89M
CDXCChromaDex Corporation
US$ 8.8999
(58.93%)
9.79M
ARBBARB IOT Group Ltd
US$ 0.80385
(54.59%)
60.1M
PRTSCarParts com Inc
US$ 1.2495
(41.80%)
5.13M
CUTRCutera Inc
US$ 0.1703
(-45.83%)
6.9M
LBGJLi Bang International Corporation Inc
US$ 1.31
(-34.50%)
164.66k
XCURExicure Inc
US$ 10.25
(-28.22%)
90.44k
TOIIWOncology Institute Inc
US$ 0.0201
(-28.21%)
303
GLSTUGlobal Star Acquisition Inc
US$ 5.69
(-22.48%)
119
ADTXAditxt Inc
US$ 0.056
(12.45%)
108.53M
GVVisionary Holdings Inc
US$ 2.255
(74.81%)
101.41M
CMRXChimerix Inc
US$ 8.4275
(69.91%)
99.89M
NVDANVIDIA Corporation
US$ 116.36
(0.32%)
93.03M
SLXNSilexion Therapeutics Corporation
US$ 1.435
(29.28%)
74.28M

URGN 財務

財務

議論

フィード全体を表示

最近閲覧した銘柄

NASDAQ
URGN
UroGen Pharma
NASDAQ
MON
Monument Circle Acquisit...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2025 ADVFN PLC - 全著作権所有

広告を削除する

サインアップして広告なしのエクスペリエンスを体験してください

広告なし

今すぐ試してください

広告を残す